Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.

European journal of gastroenterology & hepatology - 1 Jul 2005

Mahmood Asif, Needham Jane, Prosser Jeanne, Mainwaring Jason, Trebble Tim, Mahy Gillian, Ramage John

Abstract excerpt

BACKGROUND: Thromboembolic disease is a significant cause of morbidity and mortality in patients with inflammatory bowel disease (IBD). A hypercoagulable state exists in IBD that may involve many components of haemostasis and is closely linked to the disease pathogenesis. It has been proposed that microvascular thrombosis and infarction may trigger the underlying inflammatory process. AIM: To determine the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activated Protein C Resistance
Share to Colitis, Ulcerative

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VIII

Share to Homocysteine

Share to Hyperhomocysteinemia

Share to Protein C

Share to Prothrombin

Share to Vitamin B 12

Source

Identifiers

PMID: 15947551
DOI: 10.1097/00042737-200507000-00008

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.PMID 15947551Read ↗

Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel diseaseSemantic proximity Read ↗

Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.Semantic proximity Read ↗

Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations in patients with inflammatory bowel disease.Semantic proximity Read ↗

Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease.Semantic proximity Read ↗

Hyperhomocystinemia in children with inflammatory bowel disease.Semantic proximity Read ↗

Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis.Semantic proximity Read ↗

Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease.Semantic proximity Read ↗

Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications.Semantic proximity Read ↗

Hypercoagulable state in idiopathic ulcerative colitis: role of hyperhomocysteinemia and hyperfibrinogenemia.Semantic proximity Read ↗

Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.Semantic proximity Read ↗

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.Semantic proximity Read ↗

Venous thrombosis and prothrombotic factors in inflammatory bowel disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.